title: The efficacy of transdermal sumatriptan is too low for general use - a response.
authors.affiliation: Department of Headache, San Francisco Clinical Research Center, San Francisco, CA, USA.
authors.forename: Jerome
authors.initials: J
authors.lastname: Goldstein
authors.forename: Timothy
authors.initials: T
authors.lastname: Smith
authors.forename: Neil
authors.initials: N
authors.lastname: Pugach
authors.forename: James
authors.initials: J
authors.lastname: Griesser
authors.forename: Terri
authors.initials: T
authors.lastname: Sebree
authors.forename: Mark
authors.initials: M
authors.lastname: Pierce
mesh_terms: D000279:Administration, Cutaneous; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000378:metabolism; D018170:Sumatriptan / Q000008:administration & dosage* / Q000493:pharmacokinetics; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018170:Sumatriptan